Clinical Trial Update: Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating continued clopidogrel dosing in patients with acute coronary syndrome after drug-eluting stent implantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED